Contract research outsourcing (CRO) is one of the emerging trends in the global healthcare industry. It involves outsourcing of various research activities, previously performed by the manufacturer, to a third-party. A number of drug makers and companies operating in the pharmaceutical, biotechnology, and medical devices sectors are nowadays outsourcing research activities to contract researchers in order to reduce manufacturing cost without compromising on the quality of the product.
The increasing cost and declining productivity of in-house healthcare research has led organizations to look for outsourcing the task to contract research organizations. Patent expirations have also added to the woes of healthcare enterprises conducting in-house research. With the globalization of the drug development process, the global healthcare contract research outsourcing market is expected to grow consistently in the near future. The contract research organizations armored with regulatory knowledge as well as the knowledge of emerging biological therapies help in the research and development of new drugs.
However, the global healthcare contract research outsourcing market is expected to be negatively affected by the issues related to the quality of the clinical research performed by contract research organizations. Regulatory frameworks regarding the same also vary across the world. This can create confusion between the client companies and contract research organizations, which are usually located in different regions. Genetic and disease profile variations as well as data confidentiality issues will also restrain the overall market.
On the basis of type of services, the global healthcare contract research outsourcing market has been segmented into clinical trial services, regulatory services, clinical data management services, medical writing services, and others. In 2010, clinical trial services dominated the overall market and was valued at US$14.21 billion. Depending on the type of destination research groups, the global healthcare contract research outsourcing market has been categorized into clinical trial laboratories, contract research organizations, and academic medical centers. With most of the pharmaceutical companies depending on contract research organizations, they are expected to gain considerable market share in the near future.
Avail a Free Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=800
The global healthcare contract research outsourcing market has been divided into four key regions: Asia, Europe, North America, and Rest of the World. North America has been the largest region for healthcare contract research outsourcing, accounting for a 64.1% share of the market. However, Asia is expected to emerge as the largest market in the next couple of years owing to the increasing number of contract research organizations coming up in the region.
Some of the key players in the global healthcare contract research outsourcing market are Covance Inc., Parexel International Corporation, Medidata Solutions, Piramal Life Sciences, and Quintiles Transnational Corporation. The key players mostly have a global presence and are tying up with the pharmaceutical and biotech firms to expand their business.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.